NDC 11523-7234
MiraLAX
Polyethylene Glycol 3350
MiraLAX is a Oral Powder, For Solution in the Human Otc Drug category. It is labeled and distributed by Bayer Healthcare Llc.. The primary component is Polyethylene Glycol 3350.
| Product ID | 11523-7234_7a193c00-eb95-64fa-e053-2a91aa0a4e48 |
| NDC | 11523-7234 |
| Product Type | Human Otc Drug |
| Proprietary Name | MiraLAX |
| Generic Name | Polyethylene Glycol 3350 |
| Dosage Form | Powder, For Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2007-02-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022015 |
| Labeler Name | Bayer HealthCare LLC. |
| Substance Name | POLYETHYLENE GLYCOL 3350 |
| Active Ingredient Strength | 17 g/17g |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
Packaging
NDC 11523-7234-1
17 g in 1 PACKET (11523-7234-1)
| Marketing Start Date | 2007-02-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 11523-7234-7 [11523723407]
MiraLAX POWDER, FOR SOLUTION
| Marketing Category | NDA |
| Application Number | NDA022015 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2007-02-01 |
| Marketing End Date | 2016-06-01 |
NDC 11523-7234-2 [11523723402]
MiraLAX POWDER, FOR SOLUTION
| Marketing Category | NDA |
| Application Number | NDA022015 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2007-02-01 |
NDC 11523-7234-3 [11523723403]
MiraLAX POWDER, FOR SOLUTION
| Marketing Category | NDA |
| Application Number | NDA022015 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2007-02-01 |
NDC 11523-7234-1 [11523723401]
MiraLAX POWDER, FOR SOLUTION
| Marketing Category | NDA |
| Application Number | NDA022015 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-02-01 |
NDC 11523-7234-4 [11523723404]
MiraLAX POWDER, FOR SOLUTION
| Marketing Category | NDA |
| Application Number | NDA022015 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2007-02-01 |
NDC 11523-7234-5 [11523723405]
MiraLAX POWDER, FOR SOLUTION
| Marketing Category | NDA |
| Application Number | NDA022015 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-02-01 |
| Marketing End Date | 2012-01-01 |
NDC 11523-7234-6 [11523723406]
MiraLAX POWDER, FOR SOLUTION
| Marketing Category | NDA |
| Application Number | NDA022015 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2007-02-01 |
NDC 11523-7234-9 [11523723409]
MiraLAX POWDER, FOR SOLUTION
| Marketing Category | NDA |
| Application Number | NDA022015 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2007-02-01 |
| Marketing End Date | 2014-01-01 |
NDC 11523-7234-8 [11523723408]
MiraLAX POWDER, FOR SOLUTION
| Marketing Category | NDA |
| Application Number | NDA022015 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2007-02-01 |
| Marketing End Date | 2016-06-01 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| POLYETHYLENE GLYCOL 3350 | 17 g/17g |
OpenFDA Data
| SPL SET ID: | d69ce3d4-7ca4-4fe3-b49e-6655e48d6963 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Medicade Reported Pricing
11523723404 MIRALAX POWDER
Pricing Unit: GM | Drug Type:
11523723403 MIRALAX POWDER
Pricing Unit: GM | Drug Type:
11523723402 MIRALAX POWDER
Pricing Unit: GM | Drug Type:
NDC Crossover Matching brand name "MiraLAX" or generic name "Polyethylene Glycol 3350"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 11523-4357 | MiraLAX | Polyethylene Glycol 3350 |
| 11523-7234 | MiraLAX | Polyethylene Glycol 3350 |
| 11523-7341 | MiraLAX | MiraLAX |
| 11523-7268 | MiraLAX | MiraLAX |
| 55154-5035 | MiraLAX | MiraLAX |
| 0113-7306 | Basic Care Clearlax | Polyethylene Glycol 3350 |
| 0113-0306 | Good Sense Clear Lax | Polyethylene Glycol 3350 |
| 0113-1023 | good sense clearlax | Polyethylene Glycol 3350 |
| 0113-6900 | injoy constipation relief | Polyethylene Glycol 3350 |
| 0224-1890 | Mighty Lax | POLYETHYLENE GLYCOL 3350 |
| 0904-6025 | peg 3350 | Polyethylene Glycol 3350 |
| 0904-6422 | PEG 3350 | POLYETHYLENE GLYCOL 3350 |
| 0574-0412 | Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 |
| 0722-6920 | Polyethylene Glycol 3350 | Polyethylene Glycol 3350 |
| 0722-6921 | Polyethylene Glycol 3350 | Polyethylene Glycol 3350 |
| 0904-6931 | Polyethylene glycol 3350 | Polyethylene glycol 3350 |
| 10135-683 | Polyethylene Glycol 3350 | Polyethylene Glycol 3350 |
| 0536-1052 | rugby PEG 3350 | POLYETHYLENE GLYCOL 3350 |
| 0363-0306 | smooth lax | Polyethylene Glycol 3350 |
| 0363-0489 | Smooth LAX | polyethylene glycol 3350 |
Trademark Results [MiraLAX]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 MIRALAX 85746766 4426594 Live/Registered |
BAYER HEALTHCARE LLC 2012-10-05 |
 MIRALAX 78686831 3120379 Live/Registered |
Bayer HealthCare LLC 2005-08-05 |
 MIRALAX 77753736 3735255 Dead/Cancelled |
BAYER CONSUMER CARE HOLDINGS LLC 2009-06-05 |
 MIRALAX 77753735 3735254 Dead/Cancelled |
BAYER CONSUMER CARE HOLDINGS LLC 2009-06-05 |
 MIRALAX 77702783 not registered Dead/Abandoned |
MSD Consumer Care, Inc. 2009-03-31 |
 MIRALAX 77097551 3412356 Dead/Cancelled |
BAYER CONSUMER CARE HOLDINGS LLC 2007-02-02 |
 MIRALAX 75622252 2982512 Dead/Cancelled |
SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. 1999-01-15 |
 MIRALAX 75109262 not registered Dead/Abandoned |
Braintree Laboratories, Inc. 1996-05-24 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.